We are MedFluid

We are committed to optimizing the quality of patient-specific medication of infectious disease

About us

The Terminator of
Super Bacteria

We apply microfluidics as our core technique to develop an in vitro diagnostic (IVD) system to support the precision medicine of antibiotics. Targeting the emergence of antimicrobial resistance (AMR) which is literally one of the ten threats to the global health in 2019 according to WHO. Our system, fAST, can carry out rapid bacteria identification within 1.5 hours, following by a multiple antibiotics combination test within 5 hours. To conclude, we are the fastest and first-in-class system in the market that can optimize three different kind of antibiotics combination to provide clinicians with accurate and personalized results.

Our Solution

Personalized Antibiotic Screening Platform - fAST

Sensitivity

Need only 1% sample of the current methods to complete AST

Rapidity

Shorten the detection time to 5 hrs from 24 hrs in traditional methods

Flexibility

Allow doctors to conduct personalized test, even can combine up to 3 different kinds of antibiotics

Our team

Work with professionals

We all come from different fields

CEO at Medfluid - Bon
Cease to struggle and you cease to live
Founder

Bon Lee

Microfluidics R&D

Co-founder of Medfluid - Phillip
The best way to predict the future is to create one
Co-founder

Phillip Lai

Marketing Strategy

Co-founder of Medfluid - Orion
Macro patience,
micro speed
Co-founder

Orion Lu

Software & Hardware

Co-founder of Medfluid - Bill
Pick up, dust off, and then carry on
Co-founder

Bill Tsai

Clinical Validation

Our Progress

We are the
best

MedFluid Progress

Our News

News

We never stop improving ourselves

Our Partners

Who work with us

We have the best partners from various industries